Literature DB >> 14531958

The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Ava J Wu1.   

Abstract

The labial salivary gland biopsy is a diagnostic test for the oral component of Sjögren's syndrome (SS) that has been the subject of controversy and re-examination for many years. Despite multiple recent challenges to the significance of this test, when correctly done, it remains one of the most informative, specific, and technically simple tests available for the oral component of SS. Because of compromised salivary gland function, patients with SS are at risk for dental caries. Within the past decade, a paradigm shift has occurred within the field of caries research. The caries process was previously thought irreversible once initiated. Research has shown that the "early" carious lesion can be remineralized. Thus, the "early" carious lesion may be prevented and even repaired. The process of remineralization requires appropriate conditions to occur, and one of those conditions is pH. Because water is often the preferred wetting agent/beverage for patients with SS, the data show that, with regard to pH, not all waters are created equal.

Entities:  

Mesh:

Year:  2003        PMID: 14531958     DOI: 10.1007/s11926-003-0009-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  45 in total

1.  Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?

Authors:  R Manthorpe; C Benoni; L Jacobsson; Z Kirtava; A Larsson; R Liedholm; C Nyhagen; H Tabery; E Theander
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

Review 2.  Proteomics technologies for the study of autoimmune disease.

Authors:  William H Robinson; Lawrence Steinman; Paul J Utz
Journal:  Arthritis Rheum       Date:  2002-04

3.  Why do some people get more cavities than others do?

Authors:  Joel H Berg
Journal:  Sci Am       Date:  2003-02       Impact factor: 2.142

4.  Comparison of labial and sublingual salivary gland biopsies in the diagnosis of Sjögren's syndrome.

Authors:  Y L Pennec; J P Leroy; J Jouquan; A Lelong; P Katsikis; P Youinou
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

5.  Subjective reports of xerostomia and objective measures of salivary gland performance.

Authors:  P C Fox; K A Busch; B J Baum
Journal:  J Am Dent Assoc       Date:  1987-10       Impact factor: 3.634

6.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

7.  Professional antigen presenting cells in minor salivary glands in Sjögren's syndrome: potential contribution to the histopathological diagnosis?

Authors:  S C van Blokland; A F Wierenga-Wolf; C G van Helden-Meeuwsen; H A Drexhage; H Hooijkaas; J P van de Merwe; M A Versnel
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

8.  Follow up study of labial salivary gland lesions in primary Sjögren's syndrome.

Authors:  J P Leroy; Y L Pennec; C Soulier; J M Berthelot; G Letoux; P Youinou
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

Review 9.  Salivary gland dysfunction: causes, symptoms, treatment.

Authors:  J C Atkinson; A J Wu
Journal:  J Am Dent Assoc       Date:  1994-04       Impact factor: 3.634

10.  Tissue engineering of complex tooth structures on biodegradable polymer scaffolds.

Authors:  C S Young; S Terada; J P Vacanti; M Honda; J D Bartlett; P C Yelick
Journal:  J Dent Res       Date:  2002-10       Impact factor: 6.116

View more
  1 in total

1.  The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.

Authors:  Esin Alpöz; Pelin Güneri; Gonca Onder; Hülya Cankaya; Yasemin Kabasakal; Timur Köse
Journal:  Clin Oral Investig       Date:  2007-11-14       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.